The effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats

Neuropharmacology

Volumn 53, Issue 5, 2007, Pages 601-608

  Mikhaylova, M ^a   Vakhitova, J V ^b   Yamidanov, R S ^b   Salimgareeva, M Kh ^b   Seredenin, S B ^c   Behnisch, T ^a,d  

^a LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^b INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^c INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^d FUDAN UNIVERSITY   (China)

Author keywords

Adamantane; CA1; Hippocampus; LTP; Synaptic plasticity

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADAMANTANE DERIVATIVE; ANISOMYCIN; CATECHOLAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LADASTEN; LEVODOPA; MEMANTINE; MESSENGER RNA; PROTEIN SYNTHESIS INHIBITOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; HIPPOCAMPUS; IN VITRO STUDY; LEARNING; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REINFORCEMENT; SHORT TERM POTENTIATION; SINGLE DRUG DOSE; VENTRAL TEGMENTUM;

ADAMANTANE; ANIMALS; BLOTTING, WESTERN; DOPAMINE; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LEVODOPA; LONG-TERM POTENTIATION; MALE; NEURONAL PLASTICITY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPSES; SYNAPTIC TRANSMISSION; TYROSINE 3-MONOOXYGENASE;

EID: 34948868386     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.07.001     Document Type: Article

References (39)

1. Barnes C.A., Danysz W., and Parsons C.G. Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. Eur. J. Neurosci. 8 (1996) 565-571
2. Behnisch T., Matsushita S., and Knopfel T. Imaging of gene expression during long-term potentiation. Neuroreport 115 (2004) 2039-2043
3. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
4. Bliss T.V.P. Neurobiology: young receptors make smart mice. Nature 401 (1999) 25-27
5. Bugaeva L.I., Verovskii V.E., Iezhitsa I.N., Kuzubova E.A., and Spasov A.A. Complex evaluation of the effect of bromantane on animal behavior. Eksp. Klin. Farmakol. 64 (2001) 7-10
6. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5274-5278
7. El-Ghundi M., O'Dowd B.F., and George S.R. Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 18 (2007) 37-66
8. Frey U., Matthies H., Reymann K.G., and Matthies H. The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro. Neurosci. Lett. 129 (1991) 111-114
9. Frey U., and Morris R.G. Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci. 21 (1998) 181-188
10. Frey U., Schroeder H., and Matthies H. Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices. Brain Res. 522 (1990) 69-75
11. Grekhova T.V., Gainetdinov R.R., Sotnikova T.D., Krasnykh L.M., Kudrin V.S., Sergeeva S.A., and Morozov I.S. The effect of bromantane, a new immunostimulant with psychostimulating action, on release and metabolism of dopamine in the dorsal striatum of freely moving rats: a microdialysis study. Biull. Eksp. Biol. Med. 119 (1995) 302-304
12. Huang Y., and Kandel E.R. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2446-2450
13. Iarkova M.A., Voronin M.V., and Seredenin S.B. Studying the mechanisms of ladasten action. Eksp. Klin. Farmakol. 68 (2005) 3-6
14. Iezhitsa I.N., Spasov A.A., and Bugaeva L.I. Effects of bromantan on offspring maturation and development of reflexes. Neurotoxicol. Teratol. 23 (2001) 213-222
15. Kuczenski R., Segal D.S., and Aizenstein M.L. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11 (1991) 2703-2712
16. Kudrin V.S., Sergeeva S.A., Krasnykh L.M., Miroshnichenko II, Grekhova T.V., and Gainetdinov R.R. The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain. Eksp. Klin. Farmakol. 58 (1995) 8-11
17. Kumer S.C., and Vrana K.E. Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67 (1996) 443-462
18. Kusuki T., Imahori Y., Ueda S., and Inokuchi K. Dopaminergic modulation of LTP induction in the dentate gyrus of intact brain. Neuroreport 8 (1997) 2037-2040
19. Leutgeb J.K., Frey J.U., and Behnisch T. LTP in cultured hippocampal-entorhinal cortex slices from young adult (P25-30) rats. J. Neurosci. Methods 130 (2003) 19-32
20. Leviel V., Guibert B., Mallet J., and Faucon-Biguet N. Induction of tyrosine hydroxylase in the rat substantia nigra by local injection of forskolin. J. Neurosci. Res. 30 (1991) 427-432
21. Morozov I.S., Efimova L.P., and Kryzhanovskii S.A. The effect of bromantane on the cardiovascular and sympathetic-adrenal systems in animals. Eksp. Klin. Farmakol. 63 (2000) 33-36
22. Morozov I.S., Efimova L.P., and Salenko I. Effects of bromantane and sidnocarb on long-term operant conditioning and its vegetative correlates in rats. Eksp. Klin. Farmakol. 63 (2000) 11-15
23. Morozov I.S., and Kleimenova N.N. The effect of bromantane on the physical work capacity of laboratory animals. Eksp. Klin. Farmakol. 61 (1998) 51-53
24. Morozov I.S., Klimova N.V., Karpova T.D., and Shestopalov S.S. The characteristics of the neuropsychotropic activity of bromantane in laboratory animals. Eksp. Klin. Farmakol. 62 (1999) 3-6
25. Morozov I.S., Klimova N.V., Sergeeva S.A., Ivanova I.A., Barchukov V.G., Kovalev G.I., Piatin B.M., and Avdiunina N.I. Adamantane derivatives enhancing body's resistance to emergencies. Vestn. Ross. Akad. Med. Nauk. (1999) 28-32
26. Morozov I.S., Pukhova G.S., Avdulov N.A., Sergeeva S.A., Spasov A.A., and Iezhitsa I.N. The mechanisms of the neurotropic action of bromantan. Eksp. Klin. Farmakol. 62 (1999) 11-14
27. Moser E., Moser M.B., and Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J. Neurosci. 13 (1993) 3916-3925
28. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12304-12308
29. Sajikumar S., and Frey J.U. Late-associativity, synaptic tagging, and the role of dopamine during LTP and LTD. Neurobiol. Learn Mem. 82 (2004) 12-25
30. Sergeeva S.A., Krapivin S.V., Losev A.S., and Morozov I.S. Correlated interconnection between pharmacokinetic and dynamic development of the pharmacologic effects of bromantane. Biull. Eksp. Biol. Med. 119 (1995) 305-308
31. Shishido T., Watanabe Y., Matsuoka I., Nakanishi H., and Niwa S. Acute methamphetamine administration increases tyrosine hydroxylase mRNA levels in the rat locus coeruleus. Brain Res. Mol. Brain Res. 52 (1997) 146-150
32. Siuniakov S.A., Grishin S.A., Teleshova E.S., Neznamov G.G., and Seredenin S.B. Pilot clinical trial of ladasten. Eksp. Klin. Farmakol. 69 (2006) 10-15
33. Thind K.K., and Goldsmith P.C. Corticotropin-releasing factor neurons innervate dopamine neurons in the periventricular hypothalamus of juvenile macaques. Synaptic evidence for a possible companion neurotransmitter. Neuroendocrinology 50 (1989) 351-358
34. Vakhitova I., Iamidanov R.S., Vakhitov V.A., and Seredenin S.B. DNA macroarray analysis of gene expression changes in rat brain after single administration of 2-aminoadamantane compound. Mol. Biol. (Mosk) 39 (2005) 276-285
35. Vakhitova I., Salimgareeva M.K., and Seredenin S.B. The effect of ladasten on the activity of cAMP-dependent protein kinases and the phosphorylation of proteins in brain cells of rats. Eksp. Klin. Farmakol. 67 (2004) 7-9
36. Vakhitova I., Salimgareeva M.K., and Seredenin S.B. Effect of ladasten on the proteinase C activity in the rat brain cells. Eksp. Klin. Farmakol. 67 (2004) 12-15
37. Vakhitova Y.V., Yamidanov R.S., Vakhitov V.A., and Seredenin S.B. The effect of ladasten on gene expression in the rat brain. Dokl. Biochem. Biophys. 401 (2005) 150-153
38. Watanabe Y., McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., and Sakai R.R. Effects of chronic social stress on tyrosine hydroxylase mRNA and protein levels. Brain Res. Mol. Brain Res. 32 (1995) 176-180
39. Wilsch V.W., Behnisch T., Jager T., Reymann K.G., and Balschun D. When are class I metabotropic glutamate receptors necessary for long-term potentiation?. J. Neurosci. 18 (1998) 6071-6080